Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7049389 combination therapy in chronic hepatitis B
CTR20211478Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linvencorvir in Chronic Hepatitis B (CHB), sponsored by Roche. Started Jun 2021; status: completed.
02
Drugs
linvencorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20211478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211478.